Get notified when STIM files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Existential event · Existential event
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Going Concern (new) — Company disclosed substantial doubt about ability to continue as going concern due to projected revenue covenant breach in March 2027 and insufficient liquidity to repay if lender calls facility.
- Debt Default (new) — Company projects it will fail to meet March 2027 revenue covenant, which could trigger facility call and inability to repay.
- Loss On Extinguishment Of Debt (new) — Company recorded $0.5M loss on debt extinguishment in Q1 2026, including prepayment penalties and write-off of deferred costs.
Neuronetics flags going-concern doubt on projected 2027 covenant breach; federal fraud probe disclosed
Filed May 5, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 6, 2025 · ~2 min read
Key Changes
-
high
Company disclosed substantial doubt about continuing operations, projecting it will breach March 2027 revenue covenant under its $65M credit facility and lack liquidity to repay if lender calls the loan.
MD&A: Liquidity & Capital Resources verify on EDGAR → -
high
Federal fraud investigation underway: U.S. Attorney's Office issued Civil Investigative Demand regarding pre-acquisition Greenbrook billing practices; Michigan and multiple state AGs also investigating.
Risk Factors: Healthcare Fraud & Abuse verify on EDGAR → -
high
Q1 2026 revenue grew 8% to $34.5M driven by clinic expansion, but growth decelerated sharply from prior year's 84% (which included Greenbrook acquisition boost); net loss improved 15% to $10.8M.
MD&A: Results of Operations verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade STIM commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify